{
    "nctId": "NCT04826211",
    "briefTitle": "Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI",
    "officialTitle": "Targeting the Future of Axillary Staging in Node Positive Breast Cancer Patients Receiving Primary Systemic Therapy. A Comparative Study Between Sentinel Node Biopsy vs PET/MRI.",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female, Node-positive Breast Cancer, Sentinel Lymph Node",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 110,
    "primaryOutcomeMeasure": "Axillary surgery vs PET/MRI.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Signed informed consent;\n* Age \\> 18 years;\n* Proven diagnosis of early BC of any size;\n* Patients candidate to primary systemic therapy (PST);\n* Positive axillary nodes at diagnosis, confirmed by either citology or histology confirmation. Patients with clear overt clinical and radiological nodal involvement might be enrolled as well without FNA or microhystology\n\nExclusion Criteria:\n\n* inflammatory BC;\n* pregnancy;\n* contraindication to PET;\n* distant metastases;\n* no surgery after PST;\n* contraindication to MRI;\n* claustrophobia;\n* allergy to the MR contrast agent;\n* severe renal insufficiency.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}